Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Bhc - The Untold Story

Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout

Bausch Health Companies Inc. (NYSE:BHC) on Tuesday agreed to indirectly acquire DURECT Corp (NASDAQ:DRRX), including a novel therapeutic molecule, larsucosterol.

Benzinga

Hairdressers call for tax reform in ‘save our salons’ Westminster protest

The British Hair Consortium wants VAT on labour costs to be cut from 20% to 10% in the Spring Statement.

The Independent UK

Protesters in Bulgaria slam bill to ban LGBTQ+ 'propaganda' in schools

Protesters rallied outside Bulgaria’s parliament on Thursday to denounce a controversial legal amendment adopted the day before that bans talk of LGBTQ+ and so-called "non-traditional sexual choices" in schools.

Radio France Internationale

From analysis to the latest developments in health,
read the most diverse news in one place.

Bulgaria Parliament Bans LGBTQ 'Promotion' In Schools

Bulgaria's parliament passed changes to its education law Wednesday, widening its scope to ban LGBTQ "propaganda" in schools in what rights groups slammed as discriminatory.

International Business Times

This Bausch Health Companies Unusually Active Option Is a No-Brainer

Bausch Health Companies had the 8th-highest Vol/OI ratio in Wednesday trading. The pharmaceutical company’s unusual options activity suggests it might have more gains ahead.

Barchart

3 Pharma Stocks to Buy for February Gains

The pharmaceutical industry is thriving due to the growing demand for quality healthcare and high-quality drugs, a rapidly aging population, and the rise in chronic diseases. To capitalize on the industry’s growth prospects, investors could consider buying fundamentally strong pharma stocks Amphastar Pharmaceuticals (AMPH), Bausch Health Companies (BHC), and ACADIA…

StockNews.com

The king of the hill preparing for a gradual descent from the peak

On an autumnal Sunday a few weeks ago at Loton Park, Scott Moran climbed out of a top-flight hillclimb car for perhaps the final time to end his career at the top of the sport. Though this is far from retirement for the Ludlow driver, it signalled the end of…

Autosport

Read news from The Economist, FT, and more,
with one subscription

UK warns Afghans stuck in Pakistan hotels to hide indoors amid refugee crackdown

Exclusive: Warning issued to families as Pakistan begins expulsion of thousands of Afghan refugees

The Independent UK

Sunak forced to bring thousands of Afghans granted sanctuary in Britain to UK from Pakistan amid safety fears

British diplomats warned ministers that Pakistan government would begin crackdown on Afghan refugees on 1 November

The Independent UK

UK shame as Pakistani police storm hotel and arrest Afghans promised sanctuary in Britain

Exclusive: British High Commission were forced to intervene to secure release of UK-bound Afghans – as ex-Army boss accuses government of ignoring allies

The Independent UK

How a Summers British Hillclimb dream became reality

Hillclimbing has always been a hotbed of design innovation, and a whole industry has grown around the construction of low-volume single-seater racing cars. Current British Hillclimb Championship contender Alex Summers has now joined the select band of drivers who have built their own car and it has taken seven years…

Autosport

Cost of living crisis gets sticky for British Honey Company

Business expects end of year results to ‘fall below’ market expectations due to economic pressures

Evening Standard

VIRI: Enrollment Complete in FORTRESS Trial; Results Expected in September 2022…

By David Bautz, PhD NASDAQ:VIRI READ THE FULL VIRI RESEARCH REPORT

Benzinga

Bausch Health's Q1 Sales, Profits Fall On Supply Chain Challenges, Cuts FY22 Outlook

Bausch Health Companies Inc (NYSE:BHC) has reported Q1 revenues of $1.92 billion, down 5% Y/Y. Excluding the unfavorable impact of foreign exchange of $41 million and divestitures & discontinuations of $72 million, revenue was flat organically compared to Q1 FY21. Adjusted net income declined to $263 million from $370 million a year…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow

RBC Capital Markets expects Bausch Health Companies Inc (NYSE: BHC) Q1 FY22 revenue of $2.02 billion (previous $2.04 billion; consensus $2.05 billion) and adjusted EBITDA of $799 million (previous $816 million; consensus $819 million).

StockNews.com

Scoop Up These 4 Buy-Rated Healthcare Stocks Trading Near 52-Week Lows

Despite the prevailing bearish investor sentiment, the healthcare industry is expected to continue growing amid an increase in global chronic diseases, rapid medical advancements, and an aging population. The stocks of quality healthcare companies Bausch Health (BHC), Teleflex (TFX), Abcam (ABCM), and Integra LifeSciences (IART) are currently trading near their…

Benzinga

Closely Watched Bausch + Lomb IPO Priced Below Expectations

Bausch + Lomb Corp (NASDAQ:BLCO) has priced its initial public offering at $18/share, falling short of expectations as it became the first big company in months to try going public in a turbulent stock market, writes Wall Street Journal. Bausch Health Companies Inc (NYSE:BHC), the parent company, raised $630 million in the offering. According to…

StockNews.com

5 Undervalued Stocks to Scoop Up in May

The market selloff caused by the difficult macroeconomic and geopolitical issues has led many quality stocks to now trade below their intrinsic values. Agilent Technologies (A), United Therapeutics (UTHR), Nissan Motor (NSANY), Bausch Health (BHC), and Encore Wire (WIRE) are examples. These names are currently trading at discounts to their…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Bausch Health Companies Q4 Sales, FY22 Outlook Lag Wall Street View

Bausch Health Companies Inc (NYSE: BHC) has reported

StockNews.com

4 Mid-Cap Pharmaceutical Stocks to Buy This Month

Despite supply chain disruptions and labor shortages, the pharma industry is well-positioned to continue growing due to the increasing medical needs of an aging population and advancements in treating chronic diseases. Therefore, amid current market volatility, we believe it could be wise to scoop up shares of quality mid-cap pharmaceutical…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.